TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05343273 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05407064 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03942211 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04723082 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study NCT04917692 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04917692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04917692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04917692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04917692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04833205 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05563207 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT05698316 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06031337 — Predictive Biomarker (PRD): SOX7 mRNA
Genes: SOX7
Study NCT06536049 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06536049 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06447441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04680780 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT04680780 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT06114680 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04917393 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05359159 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05880693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04875585 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05635630 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04844216 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02312037 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04776005 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05534113 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06165640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05676008 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04785287 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06508749 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05587712 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04707716 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT05065619 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00080613 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04826250 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01733134 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06321159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05634889 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05634889 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05820789 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05455658 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05455658 — Predictive Biomarker (PRD): YBX1 mRNA
Genes: YBX1; NSEP1; YB1
Study NCT05455658 — Predictive Biomarker (PRD): SOX2 mRNA
Genes: SOX2
Study NCT05455658 — Predictive Biomarker (PRD): M-phase inducer phosphatase 2
Genes: CDC25B; CDC25HU2
Study NCT05066334 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06248645 — Predictive Biomarker (PRD): ATP1A3 mRNA
Genes: ATP1A3
Study NCT05062096 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04534140 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06613503 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05535621 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06062316 — Predictive Biomarker (PRD): DCN mRNA
Genes: DCN; SLRR1B
Study NCT04584086 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study NCT06496451 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT04609540 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05814068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06021106 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05205096 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05727683 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05667597 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06291454 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study NCT06291454 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study NCT06667310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06677775 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04744662 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04744662 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT05830760 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04634877 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05064280 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04936490 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT05492448 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05361408 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05858983 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT06492408 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06492408 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06492408 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06334744 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05749016 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06432140 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT05940259 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05741502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05200364 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06369610 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05762445 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00000860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05049629 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05099731 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT05887687 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06365814 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04320888 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04900363 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06294561 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06043375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05919108 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06003231 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04903652 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00990041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05042791 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05302193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05597839 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05597839 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05696145 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05696145 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06377683 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06441409 — Predictive Biomarker (PRD): Liver iron
Study NCT05523960 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT04836182 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT04836182 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06593405 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06679387 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05524142 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT04763291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04909645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06120608 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05552196 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT04341935 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06043713 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05783518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05783518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06257732 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05029661 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05768555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06648096 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04483414 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05449899 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05608252 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05787912 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05922436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05894031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02190786 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05467540 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT06120660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04846439 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04846439 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04846439 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT04560517 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05181267 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04732650 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06435013 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04914312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06679426 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06679426 — Monitoring Biomarker (MOI): Complement C4
Study NCT05604651 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT05604651 — Predictive Biomarker (PRD): MUC4 mRNA
Genes: MUC4
Study NCT05604651 — Predictive Biomarker (PRD): MUC20 mRNA
Genes: MUC20; KIAA1359; UNQ2782/PRO7170
Study NCT06279078 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06279078 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05567627 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT05590390 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05433831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04518553 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05427994 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05194709 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT05380726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06177405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05577416 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05051397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05718297 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05592483 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05737563 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06532279 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT05911919 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT05600192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05765617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06349486 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06349486 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04510792 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06111664 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05154344 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06329804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05137236 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05754099 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06088641 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05505825 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05505825 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05752552 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05810701 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT06321055 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT06321055 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT05281406 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05312996 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study NCT06594367 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT06624371 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04734704 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05878353 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06094894 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study NCT06094894 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT06094894 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05274191 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05419817 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05972564 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06145685 — Safety Biomarker (SAF): Interleukin 1
Study NCT04984356 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06157892 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04953156 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04597411 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05513469 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05232136 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05955937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06545305 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT04952168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02919189 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04736862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06093204 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04760444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06679244 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00000680 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05965557 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05965557 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04924699 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04904445 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06463639 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05868824 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT02473497 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02473497 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06458257 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT05716347 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05419492 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT06628609 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04737174 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05005637 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00006434 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06562543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05014880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05948033 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05328440 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05328440 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05626387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT06462144 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06094816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00015704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00015704 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05632484 — Predictive Biomarker (PRD): ACVRL1 mRNA
Genes: ACVRL1; ACVRLK1; ALK1
Study NCT05632484 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05632484 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT05632484 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study NCT06081998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06678230 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT06678230 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT06678230 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06678230 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00000989 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00000989 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05193422 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05043740 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05065541 — Predictive Biomarker (PRD): MGLL mRNA
Genes: MGLL
Study NCT05065541 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study NCT06640751 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05019040 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06283238 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT06283238 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study NCT06066424 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT06066424 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT06452394 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06452394 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study NCT06452394 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06452394 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05362916 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04580420 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT06001762 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06001762 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06001762 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06001762 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT06001762 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06001762 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06001762 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04809662 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04809662 — Predictive Biomarker (PRD): FUT2 mRNA
Genes: FUT2; SEC2
Study NCT04957615 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT05895578 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05057754 — Surrogate Endpoint (SUR): Blood pressure